RELATED CONTENT
Unlike most brain studies where scientists watch as people respond to cues or commands, Johns Hopkins researchers found a way to observe people’s brain activity as they made choices entirely on their own.
July 15, 2016 
Two studies from Johns Hopkins Kimmel Cancer Center add to preliminary evidence that stereotactic body radiotherapy (SBRT) appears as safe and effective as standard radiation treatment for certain patients with pancreatic cancer whose tumors are advanced but have not spread.
May 19, 2015 ![prostate cancer, [18F]DCFPyL, PSMA, biomarker, Johns Hopkins, WMIS](/sites/default/files/styles/feed_medium/public/Prostate%20cancer%20F18.jpg?itok=6RsnuKcp)
A first-in-human prostate cancer study in the Journal of Molecular Imaging and Biology showed initial safety, biodistribution and dosimetry results with [18F]DCFPyL, a second-generation fluorine-18 labeled small-molecule prostate-specific membrane antigen (PSMA) inhibitor. The imaging biomarker has been developed at Johns Hopkins University in Baltimore by study co-author Martin G. Pomper, M.D., Ph.D.
April 30, 2015 
Researchers from Johns Hopkins performing sophisticated motion studies of heart magnetic resonance imaging (MRI) scans have found that specific altered function in the left atrium may signal stroke risk in those with atrial fibrillation and those without it.
April 28, 2015 
Results of a Johns Hopkins study suggest magnetic resonance imaging (MRI) could one day make biopsies more effective or replace them altogether in determining if a tumor is or isn’t cancer. The MRI technique, so far tested only in test tube-grown cells and mice, is described in a report published March 27 in the online journal Nature Communications.
March 30, 2015 
Tomotherapy and volumetric modulated arc therapy (VMAT) have emerged as two popular types of intensity modulated radiation therapy (IMRT) for the treatment of complex tumors. Because physicians can modulate or control the intensity of the radiation beam in VMAT and tomotherapy, both treatments provide high precision radiation with which tumors that are curved around critical organs can be treated.
July 03, 2014 
A 320-detector computed tomography (CT) scanner that shows both anatomy within coronary arteries and blood flow can accurately sort out which people need an invasive procedure to identify coronary blockages, according to an international study.
November 22, 2013 
August 30, 2012 — An ultra-fast, 320-detector computed tomography (CT) scanner can accurately sort out which people with chest pain need – or don’t need – an invasive procedure such as cardiac angioplasty or bypass surgery to restore blood flow to the heart, according to an international study.
August 30, 2012 
February 13, 2012 — Peake Healthcare Innovations, a joint venture between Harris Corporation and Johns Hopkins Medicine, announced a new approach to medical image management.
February 13, 2012 
Feb. 18, 2010 — Johns Hopkins Medicine has become the latest academic medical center to acquire the Naviscan Positron Emission Mammography (PEM) scanner. The device will be utilized by Richard Wahl, M.D., F.A.C.R, professor of radiology and nuclear medicine at the Johns Hopkins University School of Medicine, in preclinical and translational research for the development of novel radiotracers.
February 19, 2010